文献速递肝病

肠道菌群驱动肝内B细胞活化通过固有和适应性信号加重NASH

Microbiota-Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling.
PubMed 文献 · Hepatology · 2021-01-01

该研究探讨B细胞在非酒精性脂肪性肝炎(NASH)中的作用。NASH肝脏中B细胞积聚并分泌促炎因子、增强抗原提呈能力;B细胞缺陷可改善NASH进展,过继转移NASH肝脏B细胞可重现疾病。机制涉及MyD88固有信号和B细胞受体适应性信号协同,且人NAFLD肠道菌群移植可促进小鼠NASH进展。

要点

  • NASH肝脏中B细胞积聚并表现出促炎和抗原提呈功能增强。
  • B细胞缺陷减轻NASH进展,过继转移NASH肝脏B细胞可重现疾病。
  • 肠道菌群通过激活肝内B细胞驱动NASH炎症和纤维化。

核心结论

  • 肠道菌群驱动的肝内B细胞活化通过固有和适应性免疫机制导致NASH进展中的肝脏炎症和纤维化。

研究设计与样本

  • 研究采用NASH小鼠模型,进行肝内B细胞单细胞和bulk RNA测序,并开展B细胞缺陷、过继转移及粪菌移植实验。

主要发现

  • NASH肝脏中B细胞积聚,促炎细胞因子分泌和抗原提呈能力升高。
  • B细胞缺陷改善NASH进展,过继转移NASH肝脏B细胞可重现疾病。
  • B细胞特异性敲除MyD88减少肝脏T细胞介导的炎症和纤维化,但不影响脂肪变性。
  • 肝内B细胞活化涉及B细胞受体信号,体现固有与适应性抗原识别机制的协同。
  • 移植人NAFLD肠道菌群给小鼠可增加肝内B细胞积聚和活化,促进NASH进展。

临床怎么用

  • 靶向肝内B细胞活化或其肠道菌群驱动因素可能成为NASH治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Nonalcoholic steatohepatitis is rapidly becoming the leading cause of liver failure and indication for liver transplantation. Hepatic inflammation is a key feature of NASH but the immune pathways involved in this process are poorly understood. B lymphocytes are cells of the adaptive immune system that are critical regulators of immune responses. However, the role of B cells in the pathogenesis of NASH and the potential mechanisms leading to their activation in the liver are unclear. APPROACH AND RESULTS: In this study, we report that NASH livers accumulate B cells with elevated pro-inflammatory cytokine secretion and antigen-presentation ability. Single-cell and bulk RNA sequencing of intrahepatic B cells from mice with NASH unveiled a transcriptional landscape that reflects their pro-inflammatory function. Accordingly, B-cell deficiency ameliorated NASH progression, and adoptively transferring B cells from NASH livers recapitulates the disease. Mechanistically, B-cell activation during NASH involves signaling through the innate adaptor myeloid differentiation primary response protein 88 (MyD88) as B cell-specific deletion of MyD88 reduced hepatic T cell-mediated inflammation and fibrosis, but not steatosis. In addition, activation of intrahepatic B cells implicates B cell-receptor signaling, delineating a synergy between innate and adaptive mechanisms of antigen recognition. Furthermore, fecal microbiota transplantation of human NAFLD gut microbiotas into recipient mice promoted the progression of NASH by increasing the accumulation and activation of intrahepatic B cells, suggesting that gut microbial factors drive the pathogenic function of B cells during NASH. CONCLUSION: Our findings reveal that a gut microbiota-driven activation of intrahepatic B cells leads to hepatic inflammation and fibrosis during the progression of NASH through innate and adaptive immune mechanisms.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Barrow F, Khan S, Fredrickson G, et al. Microbiota-Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling. Hepatology. 2021. PMID: 33609303. doi:10.1002/hep.31755

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。